Zacharia, B. E. et al. Incidence, treatment and survival of patients with craniopharyngioma in the Surveillance, Epidemiology and End Results Program. Neurooncology 14, 1070–1078 (2012).
Muller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J. P. & Puget, S. Craniopharyngioma. Nat. Rev. Dis. Prim. 5, 75 (2019).
van Iersel, L. et al. Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review. Endocr. Rev. 40, 193–235 (2019). A comprehensive review of hypothalamic dysfunction and all reported interventions aiming to improve hypothalamic obesity, and a proposed treatment algorithm.
Muller, H. L. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr. Opin. Endocrinol. Diabetes Obes. 23, 81–89 (2016).
Article CAS PubMed Google Scholar
Muller, H. L. Consequences of craniopharyngioma surgery in children. J. Clin. Endocrinol. Metab. 96, 1981–1991 (2011).
Article CAS PubMed Google Scholar
Muller, H. L. The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110, 753–766 (2020).
Article CAS PubMed Google Scholar
Sterkenburg, A. S. et al. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neurooncology 17, 1029–1038 (2015). A a 20-year follow-up analysis of 485 patients with childhood-onset craniopharyngioma that showed impaired overall survival in patients with hypothalamic involvement. Relapse and progression rates were similar with regard to different degrees of resection (gross total resection versus incomplete resection).
Otte, A. & Müller, H. L. Childhood-onset craniopharyngioma. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/clinem/dgab397 (2021). A recent comprehensive review of craniopharyngioma.
Muller, H. L., Merchant, T. E., Puget, S. & Martinez-Barbera, J. P. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat. Rev. Endocrinol. 13, 299–312 (2017).
Harz, K. J., Muller, H. L., Waldeck, E., Pudel, V. & Roth, C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J. Clin. Endocrinol. Metab. 88, 5227–5231 (2003).
CAS Article PubMed Google Scholar
Prader, A. Ein Syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter [German]. Schweiz. Med. Wochenschr. 86, 1260–1261 (1956).
Cemeroglu, A. P., Coulas, T. & Kleis, L. Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study. J. Pediatr. Endocrinol. Metab. 28, 1057–1063 (2015).
Tauber, M. & Hoybye, C. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol. 9, 235–246 (2021). A recent comprehensive review of hypothalamic dysfunction in patients with PWS.
CAS Article PubMed Google Scholar
Muller, H. L. Management of endocrine disease: childhood-onset craniopharyngioma: state of the art of care in 2018. Eur. J. Endocrinol. 180, R159–R174 (2019).
Muller, H. L. Hypothalamic involvement in craniopharyngioma – implications for surgical, radiooncological, and molecularly targeted treatment strategies. Pediatr. blood cancer 65, e26936 (2018).
Parkinson, W. L. & Weingarten, H. P. Dissociative analysis of ventromedial hypothalamic obesity syndrome. Am. J. Physiol. 259, R829–R835 (1990).
Bunin, G. R. et al. The descriptive epidemiology of craniopharyngioma. J. Neurosurg. 89, 547–551 (1998).
CAS Article PubMed Google Scholar
Santagata, S., Kleinschmidt-DeMasters, B. K., Komori, T., Müller, H. L., Pietsch, T. in Central Nervous System Tumours. WHO Classification of Tumours 5th edn Vol. 6 (WHO Classification of Tumours Editorial Board) 393–396 (IARC, 2021).
Hafez, M. A., ElMekkawy, S., AbdelBadie, H., Mohy, M. & Omar, M. Pediatric craniopharyngioma – rationale for multimodal management: the Egyptian experience. J. Pediatr. Endocrinol. Metab. 19 (Suppl. 1), 371–380 (2006).
Zhang, Y. Q., Wang, C. C. & Ma, Z. Y. Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr. Neurosurg. 36, 80–84 (2002).
Adeloye, A., Nottidge, V. A. & Udi, J. Craniopharyngioma in Nigerian children. Childs Nerv. Syst. 4, 128–134 (1988).
CAS Article PubMed Google Scholar
Ersahin, Y., Yurtseven, T., Ozgiray, E. & Mutluer, S. Craniopharyngiomas in children: Turkey experience. Childs Nerv. Syst. 21, 766–772 (2005).
Amayiri, N. et al. Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience. Childs Nerv. Syst. 33, 941–950 (2017).
Chaudhry, N. S., Raber, M. R., Cote, D. J. & Laws, E. R. Jr. Spontaneous pituitary adenoma occurring after resection of a Rathke’s cleft cyst. J. Clin. Neurosci. 33, 247–251 (2016).
Suh, Y. L. et al. Tumors of the central nervous system in Korea: a multicenter study of 3221 cases. J. Neurooncol. 56, 251–259 (2002).
Gittleman, H. et al. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. J. Neurooncol. 143, 251–260 (2019).
Kakkar, A. et al. Erratum to: Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India. Childs Nerv. Syst. 32, 2181 (2016).
Keene, D. et al. Epidemiological survey of central nervous system germ cell tumors in Canadian children. J. Neurooncol. 82, 289–295 (2007).
CAS Article PubMed Google Scholar
Lee, S. H. et al. Nationwide population-based incidence and survival rates of malignant central nervous system germ cell tumors in Korea, 2005-2012. Cancer Res. Treat. 49, 494–501 (2017).
Kuratsu, J., Takeshima, H. & Ushio, Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int. J. Clin. Oncol. 6, 183–191 (2001).
Peckham-Gregory, E. C. et al. Evaluation of racial disparities in pediatric optic pathway glioma incidence: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014. Cancer Epidemiol. 54, 90–94 (2018).
Article PubMed PubMed Central Google Scholar
Avery, R. A. et al. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1. Neurology 86, 2264–2270 (2016).
Article PubMed PubMed Central Google Scholar
Guyot-Goubin, A. et al. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr. Blood Cancer 51, 71–75 (2008).
Salotti, J. A. et al. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch. Dis. Child. 94, 376–380 (2009).
CAS Article PubMed Google Scholar
Horibe, K. et al. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology. Int. J. Hematol. 98, 74–88 (2013).
Stalemark, H. et al. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr. Blood Cancer 51, 76–81 (2008).
Alston, R. D. et al. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr. Blood Cancer 48, 555–560 (2007).
CAS Article PubMed Google Scholar
Makras, P., Stathi, D., Yavropoulou, M., Tsoli, M. & Kaltsas, G. The annual incidence of Langerhans cell histiocytosis among adults living in Greece. Pediatr. Blood Cancer 67, e28422 (2020).
Passone, C. G. B. et al. Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr. Open 4, e000630 (2020).
Article PubMed PubMed Central Google Scholar
Whittington, J. E., Butler, J. V. & Holland, A. J. Changing rates of genetic subtypes of Prader-Willi syndrome in the UK. Eur. J. Hum. Genet. 15, 127–130 (2007).
CAS Article PubMed Google Scholar
Bar, C. et al. Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome. Orphanet J. Rare Dis. 12, 118 (2017).
Article PubMed PubMed Central Google Scholar
Smith, A. et al. Birth prevalence of Prader-Willi syndrome in Australia. Arch. Dis. Child. 88, 263–264 (2003).
CAS Article PubMed PubMed Central Google Scholar
Vogels, A. et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur. J. Hum. Genet. 12, 238–240 (2004).
CAS Article PubMed Google Scholar
Lionti, T., Reid, S. M., White, S. M. & Rowell, M. M. A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am. J. Med. Genet. A 167A, 371–378 (2015).
Patel, L., McNally, R. J., Harrison, E., Lloyd, I. C. & Clayton, P. E. Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England. J. Pediatr. 148, 85–88 (2006).
Khaper, T. et al. Increasing incidence of optic nerve hypoplasia/septo-optic dysplasia spectrum: Geographic clustering in Northern Canada. Paediatr. Child. Health 22, 445–453 (2017).
留言 (0)